Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. - Wikidata - awgldk - TriplyDB

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

http://www.wikidata.org/entity/Q34332159

about

Intracellular Aβ pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study.Untangling tau imaging Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis The amyloid hypothesis of Alzheimer's disease at 25 years Exercise-Related Changes of Networks in Aging and Mild Cognitive Impairment Brain Advances in development of fluorescent probes for detecting amyloid-β aggregates Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease Modulation of neurotrophic signaling pathways by polyphenols Suspected non-Alzheimer disease pathophysiology--concept and controversy Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015 Diverse molecular targets for therapeutic strategies in Alzheimer's disease The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations Self-propagation of pathogenic protein aggregates in neurodegenerative diseases Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation Transnasal delivery of human A-beta peptides elicits impaired learning and memory performance in wild type mice.Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease Tau Biology and Tau-Directed Therapies for Alzheimer's Disease Defining the earliest pathological changes of Alzheimer's disease Three dimensions of the amyloid hypothesis: time, space and 'wingmen'Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease Genetic variants in Alzheimer disease - molecular and brain network approaches Imago Mundi, Imago AD, Imago ADNI PET neuroimaging studies of [(18)F]CABS13 in a double transgenic mouse model of Alzheimer's disease and nonhuman primates Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship.Arterial stiffness and β-amyloid progression in nondemented elderly adults.Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.Imaging plus X: multimodal models of neurodegenerative disease.Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease A data-driven model of biomarker changes in sporadic Alzheimer's disease.Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Brain connectivity in neurodegenerative diseases--from phenotype to proteinopathy.A review of β-amyloid neuroimaging in Alzheimer's disease.A computational method for computing an Alzheimer's disease progression score; experiments and validation with the ADNI data set.

P2860

Q22001054-2595AB59-C9BC-49FE-881E-83D2DE674E85 Q26739091-05743192-27C6-40E1-A7AC-1BC25E08716D Q26744866-667973DB-CF96-40B2-9817-984302B47C45 Q26749528-2BB0650D-A6A9-4832-AE88-D53E50ABFD50 Q26751170-DFD3CD54-B1B9-4296-973E-7FC971254232 Q26753175-24A7A404-C256-47D4-88E6-6E46621A8865 Q26767264-73621F57-8170-4189-81BF-F80B632858B6 Q26771195-EB078E28-C911-48F3-B576-3E5A912A7335 Q26771270-1243A769-9DDE-409F-BC79-D0654002EC23 Q26773657-F1021E95-94DB-46A3-BF69-13BB6B941D0F Q26801654-F1E3D10D-5E87-4D75-A73C-BD065DC62CE9 Q26827193-D8F8DD6D-2B9F-4A6F-A9B2-C6D519310AF2 Q26830467-9D87B23B-ABDB-4EAF-A965-D029CE7B0F0C Q26996441-C2299562-C643-431E-B8AD-715EC8EE422E Q27007436-28100558-C0B2-4659-81AE-A2782B698B93 Q27303745-76EE4C50-7149-4DC8-8FD9-7B6BCDAD6BA3 Q27315991-9AA83A13-6EE1-428D-BF07-E512984A2E06 Q27336341-CBE9C5F8-09FE-41CB-9FF7-E2688615E04C Q27345258-42CF9B9E-2223-454C-9BF0-66268CA54A5B Q27346441-E9ABB789-2CFF-42E9-8D96-B19FA34FA401 Q28005463-436E9999-958F-4832-9D87-8C8E38797D46 Q28071398-EB7EA73B-7196-45B5-B917-EE912191917F Q28081435-218C37D9-03C3-4690-A85E-CDEC2E3B8DE5 Q28082768-452FFD7F-8263-4850-B90B-0750455EF848 Q28273817-003CF20A-0F54-4100-A558-FAB914E97647 Q28547333-A8ADCC30-DC80-45EB-A430-A21B654936E3 Q28596011-9E9503A9-EFF0-4C66-8880-C8552789D51A Q28650395-88B480B3-EC33-4FB6-A3D3-CD4B7252716C Q28833503-4F9A43B2-CDD9-4E5B-98B5-DFC1D5F24111 Q30101023-A5E9F732-67D8-4257-A5BB-2C715D69C88E Q30409084-3A95B804-85BF-4431-98E2-0F4470CC365B Q30409644-EAF1DACF-959D-470A-A5F3-EAF21C043721 Q30491715-F25B7168-931F-4469-AE9D-D5B1F27D7AA8 Q30557788-681D09B8-9136-43BF-B918-42392E9E0377 Q30835966-87760B2C-5D58-4EBC-B8D1-A10D53A8E551 Q30842997-55AF214F-D035-438A-9893-C8720D95605B Q30845482-4F1E2197-44E5-4D09-83E9-50F246A33C10 Q30857734-7E466C19-3BB5-4D32-83BF-781D29E5CCF8 Q30870063-C783213F-0F88-42F1-8C3C-B843F567D7F5 Q30872852-51031530-1C9E-49ED-85C0-97BCDB26F33F

P2860

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

http://www.wikidata.org/entity/Q34332159

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@ast

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@en

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@nl

type

label

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@ast

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@en

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@nl

prefLabel

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@ast

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@en

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@nl

P1433

Q34332159-F1AF86E3-C9D6-47AC-BD58-0999C1B8E246

P1476

Q34332159-8F19EACD-5336-44EB-B299-1D1CF6C6B754

P2093

Q34332159-5018C0D8-77A3-4BFD-9F76-2D045630B164

Q34332159-608BFC9E-D722-442B-9B7D-0EA5E35510EE

Q34332159-91C44B43-4862-459F-B5C0-39E6DF815F33

Q34332159-D25313A5-00C3-4381-A46D-F540BDFA6BD5

Q34332159-DC812722-2385-4862-AE23-E6E9DEBEA90A

Q34332159-FC310BD4-B330-4800-AD8D-9DB79D51B486

P304

Q34332159-2D4061A4-922C-4386-8197-53206FE4BD3D

P31

Q34332159-8C95C586-6766-4954-BCBC-E4B677515279

P356

Q34332159-40036CFB-D9D0-4598-A590-8B0E05A44E32

P433

Q34332159-B071A08D-A3C1-450D-9321-E040E125EE5E

P478

Q34332159-67DBBC57-6F26-42A1-A330-5036F99BBF2A

P50

Q34332159-1A6371C1-F931-4714-8590-654DAA63352B

Q34332159-334C956C-C061-4A47-9359-EE025385A825

Q34332159-4291C786-BB87-47CA-A10C-5A004241F350

Q34332159-68CC16F2-07AD-4783-93FD-67CFAD02DBC8

Q34332159-A2E7EB67-08C2-4FE5-8F95-8402DB6D5814

Q34332159-C2B94CE8-97E4-4FFF-A78A-3B8162A64B17

Q34332159-C8E6C0DA-FB14-4F7A-92BC-94478DAE5062

Q34332159-CD918FFF-E22A-4ED0-B470-09AC81913681

P577

Q34332159-CBCF70DE-C379-4661-91A7-4EF74B149375

P698

Q34332159-2F166138-6FC9-4DA1-B2FA-4A502C7B10CE

P921

Q34332159-4AD38DF6-0F82-467D-AD10-51CCBCDB76B0

P356

S1474-4422(13)70044-9

P1433

Lancet Neurology

P1476

Amyloid β deposition, neurodeg ...... e: a prospective cohort study.

@en

P2093

Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group

http://www.w3.org/2001/XMLSchema#string

Belinda Brown

http://www.w3.org/2001/XMLSchema#string

Christopher C Rowe

http://www.w3.org/2001/XMLSchema#string

David Ames

http://www.w3.org/2001/XMLSchema#string

S Lance Macaulay

http://www.w3.org/2001/XMLSchema#string

Victor L Villemagne

http://www.w3.org/2001/XMLSchema#string

P304

357-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(13)70044-9

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Colin L. Masters

Cassandra Szoeke

Pierrick Bourgeat

Olivier Salvado

Samantha Burnham

Kathryn A Ellis

P577

2013-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23477989

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease